Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours
Authors:
- Yaxin AnYAYaxin An
- Jimmy MasjkurJMJimmy Masjkur
- Katharina LangtonKLKatharina Langton
- Mirko PeitzschMPMirko Peitzsch
- Timo DeutschbeinTDTimo Deutschbein
- Martin FassnachtMFMartin Fassnacht
- Natalie Rogowski-LehmannNRNatalie Rogowski-Lehmann
- Felix BeuschleinFBFelix Beuschlein
- Stephanie FliednerSFStephanie Fliedner
- Anthony StellASAnthony Stell
- Aleksander PrejbiszAPAleksander Prejbisz
- 3 March 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 43 (2) , 263-275
Abstract
Obesity-associated activation of sympathetic nervous outflow is well documented, whereas involvement of dysregulated adrenomedullary hormonal function in obesity is less clear. This study assessed relationships of sympathoadrenal function with indices of obesity and influences of circulating catecholamines on body mass. Anthropometric and clinical data along with plasma and 24-h urine samples were collected from 590 volunteers and 1368 patients tested for phaeochromocytoma and paraganglioma (PPGL), among whom tumours were diagnosed in 210 individuals. Among patients tested for PPGL, those with tumours less often had a body mass index (BMI) above 30 kg/m2 (12 vs. 31%) and more often a BMI under 25 kg/m2 (56 vs. 32%) than those without tumours (P < 0.0001). Urinary outputs of catecholamines in patients with PPGL were negatively related to BMI (r = −0.175, P = 0.0133). Post-operative weight gain (P < 0.0001) after resection of PPGL was positively related to presurgical tumoural catecholamine output (r = 0.257, P = 0.0101). Higher BMI in men and women and percent body fat in women of the volunteer group were associated with lower plasma concentrations and urinary outputs of adrenaline and metanephrine, the former indicating obesity-related reduced adrenaline secretion and the latter obesity-related reduced adrenomedullary adrenaline stores. Daytime activity was associated with substantial increases in urinary adrenaline and noradrenaline excretion, with blunted responses in obese subjects. The findings in patients with PPGL support an influence of high circulating catecholamines on body weight. Additional associations of adrenomedullary dysfunction with obesity raise the possibility of a permissive influence of the adrenal medulla on the regulation of body weight.Keywords
This publication has 48 references indexed in Scilit:
- Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolitesClinica Chimica Acta, 2013
- Trend in Obesity Prevalence in European Adult Cohort Populations during Follow-up since 1996 and Their Predictions to 2015PLOS ONE, 2011
- Endogenous epinephrine protects against obesity induced insulin resistanceAutonomic Neuroscience, 2011
- Resistant Hypertension: Diagnosis, Evaluation, and TreatmentHypertension, 2008
- Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese menDiabetologia, 2007
- Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) ObesityDiabetes Care, 2006
- Sympathetic Activation in Obese Normotensive SubjectsHypertension, 1995
- Concentrations of noradrenaline at neuronal uptakes sites during sympathetic nervous inhibition and activation in rabbitsNeurochemistry International, 1993
- Body Fat and the Activity of the Autonomic Nervous SystemNew England Journal of Medicine, 1988
- Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation, 1979